Skip to main content

Bellahist-D LA Drug Interactions

Currently displaying 480 drugs known to have a moderate interaction with Bellahist-D LA (atropine / chlorpheniramine / hyoscyamine / phenylephrine / scopolamine).

View all medications that may interact with Bellahist-D LA (atropine / chlorpheniramine / hyoscyamine / phenylephrine / scopolamine) or return to the list of commonly checked interactions in combination with this medicine.

Moderate interactions with Bellahist-D LA (atropine / chlorpheniramine / hyoscyamine / phenylephrine / scopolamine)

Note: Showing generic names only.

A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
Z

Bellahist-D LA alcohol/food interactions

There are 5 alcohol/food interactions with Bellahist-D LA (atropine / chlorpheniramine / hyoscyamine / phenylephrine / scopolamine).

Bellahist-D LA disease interactions

There are 27 disease interactions with Bellahist-D LA (atropine / chlorpheniramine / hyoscyamine / phenylephrine / scopolamine) which include:


Report options

Loading...
QR code containing a link to this page

More about Bellahist-D LA (atropine / chlorpheniramine / hyoscyamine / phenylephrine / scopolamine)

Related treatment guides

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.